These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 37199059)
21. Generation of an optimized lentiviral vector encoding a high-expression factor VIII transgene for gene therapy of hemophilia A. Johnston JM; Denning G; Doering CB; Spencer HT Gene Ther; 2013 Jun; 20(6):607-15. PubMed ID: 22996197 [TBL] [Abstract][Full Text] [Related]
22. Intraosseous delivery of platelet-targeted factor VIII lentiviral vector in humanized NBSGW mice. Joo JH; Wang X; Singh S; Chen CY; Li C; Adair JE; Kiem HP; Rawlings DJ; Miao CH Blood Adv; 2022 Oct; 6(19):5556-5569. PubMed ID: 35849710 [TBL] [Abstract][Full Text] [Related]
23. Adenovirus-mediated factor VIII gene expression results in attenuated anti-factor VIII-specific immunity in hemophilia A mice compared with factor VIII protein infusion. Bristol JA; Gallo-Penn A; Andrews J; Idamakanti N; Kaleko M; Connelly S Hum Gene Ther; 2001 Sep; 12(13):1651-61. PubMed ID: 11535168 [TBL] [Abstract][Full Text] [Related]
24. Single cell Raman spectroscopy to identify different stages of proliferating human hepatocytes for cell therapy. Ma C; Zhang L; He T; Cao H; Ren X; Ma C; Yang J; Huang R; Pan G Stem Cell Res Ther; 2021 Oct; 12(1):555. PubMed ID: 34717753 [TBL] [Abstract][Full Text] [Related]
25. Evaluation of high-fat high-fructose diet treatment in factor VIII (coagulation factor)-deficient mouse model. Mishra A; Arindkar S; Sahay P; Kumar JM; Upadhyay PK; Majumdar SS; Nagarajan P Int J Exp Pathol; 2018 Feb; 99(1):46-53. PubMed ID: 29656466 [TBL] [Abstract][Full Text] [Related]
27. Curing hemophilia A by NHEJ-mediated ectopic F8 insertion in the mouse. Zhang JP; Cheng XX; Zhao M; Li GH; Xu J; Zhang F; Yin MD; Meng FY; Dai XY; Fu YW; Yang ZX; Arakaki C; Su RJ; Wen W; Wang WT; Chen W; Choi H; Wang C; Gao G; Zhang L; Cheng T; Zhang XB Genome Biol; 2019 Dec; 20(1):276. PubMed ID: 31843008 [TBL] [Abstract][Full Text] [Related]
28. CD47 and PD-L1 overexpression in proliferating human hepatocytes attenuated immune responses and ameliorated acute liver injury in mice. Ma C; Cao H; Sun Z; Deng Q; Liu W; Xin Y; Qiao S; Cen J; Shu Y; Qi K; Han L; Zhang L; Pan G Am J Transplant; 2023 Dec; 23(12):1832-1844. PubMed ID: 37532180 [TBL] [Abstract][Full Text] [Related]
30. Bone marrow mesenchymal cells for haemophilia A gene therapy using retroviral vectors with modified long-terminal repeats. Van Damme A; Chuah MK; Dell'accio F; De Bari C; Luyten F; Collen D; VandenDriessche T Haemophilia; 2003 Jan; 9(1):94-103. PubMed ID: 12558785 [TBL] [Abstract][Full Text] [Related]
31. Onco-retroviral and lentiviral vector-based gene therapy for hemophilia: preclinical studies. Van Damme A; Chuah MK; Collen D; VandenDriessche T Semin Thromb Hemost; 2004 Apr; 30(2):185-95. PubMed ID: 15118930 [TBL] [Abstract][Full Text] [Related]
32. Safety of intra-articular transplantation of lentivirally transduced mesenchymal stromal cells for haemophilic arthropathy in a non-human primate. Ohmori T; Mizukami H; Katakai Y; Kawai S; Nakamura H; Inoue M; Shu T; Sugimoto H; Sakata Y Int J Hematol; 2018 Sep; 108(3):239-245. PubMed ID: 29737459 [TBL] [Abstract][Full Text] [Related]
33. Preclinical and clinical gene therapy for haemophilia. Chuah MK; Collen D; Vandendriessche T Haemophilia; 2004 Oct; 10 Suppl 4():119-25. PubMed ID: 15479384 [TBL] [Abstract][Full Text] [Related]
34. Characterization of Adeno-Associated Viral Vector-Mediated Human Factor VIII Gene Therapy in Hemophilia A Mice. Greig JA; Wang Q; Reicherter AL; Chen SJ; Hanlon AL; Tipper CH; Clark KR; Wadsworth S; Wang L; Wilson JM Hum Gene Ther; 2017 May; 28(5):392-402. PubMed ID: 28056565 [TBL] [Abstract][Full Text] [Related]
35. Extrahepatic sources of factor VIII potentially contribute to the coagulation cascade correcting the bleeding phenotype of mice with hemophilia A. Zanolini D; Merlin S; Feola M; Ranaldo G; Amoruso A; Gaidano G; Zaffaroni M; Ferrero A; Brunelleschi S; Valente G; Gupta S; Prat M; Follenzi A Haematologica; 2015 Jul; 100(7):881-92. PubMed ID: 25911555 [TBL] [Abstract][Full Text] [Related]
36. A highly efficient, stable, and rapid approach for ex vivo human liver gene therapy via a FLAP lentiviral vector. Giannini C; Morosan S; Tralhao JG; Guidotti JE; Battaglia S; Mollier K; Hannoun L; Kremsdorf D; Gilgenkrantz H; Charneau P Hepatology; 2003 Jul; 38(1):114-22. PubMed ID: 12829993 [TBL] [Abstract][Full Text] [Related]
37. Establishment of a strain of haemophilia-A pigs by xenografting of foetal testicular tissue from neonatally moribund cloned pigs. Kaneko H; Kikuchi K; Nakai M; Fuchimoto D; Suzuki S; Sembon S; Noguchi J; Onishi A Sci Rep; 2017 Dec; 7(1):17026. PubMed ID: 29208927 [TBL] [Abstract][Full Text] [Related]
38. Usefulness of an in vitro cellular expression model for haemophilia A carrier diagnosis: illustration with five novel mutations in the F8 gene in women with isolated factor VIII:C deficiency. Roualdes O; Nougier C; Fretigny M; Talagrand E; Durand B; Negrier C; Vinciguerra C Haemophilia; 2015 May; 21(3):e202-e209. PubMed ID: 25708597 [TBL] [Abstract][Full Text] [Related]
39. Characterization of F8 defects in haemophilia A in Pakistan: investigation of correlation between mutation type and the in vitro thrombin generation assay. Khanum F; Collins PW; Harris RL; Bowen DJ Haemophilia; 2014 Mar; 20(2):287-93. PubMed ID: 24118398 [TBL] [Abstract][Full Text] [Related]
40. Therapeutic factor VIII levels and negligible toxicity in mouse and dog models of hemophilia A following gene therapy with high-capacity adenoviral vectors. Chuah MK; Schiedner G; Thorrez L; Brown B; Johnston M; Gillijns V; Hertel S; Van Rooijen N; Lillicrap D; Collen D; VandenDriessche T; Kochanek S Blood; 2003 Mar; 101(5):1734-43. PubMed ID: 12406898 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]